Grant Bogle

Grant Bogle

Direktör/Styrelseledamot på
Gladius Therapeutics, Inc.
68 år
Health Technology
Health Services
Consumer Services

Profil

Grant C.
Bogle
is currently Director at Gladius Therapeutics, Inc., Myrobalan Therapeutics, Inc., and American School for the Deaf.
Former roles include President, Chief Executive Officer, CFO & Director at Epizyme, Inc. from 2021 to 2022; Independent Director at Nuvalent, Inc. from 2024 to 2026; Principal at EIDP, Inc., Roche Pharmaceuticals, Inc., Abbott India Ltd., and American Hospital Supply Corp.; Senior Vice President-Sales & Marketing at Millennium Pharmaceuticals, Inc.; EVP-Strategy & Emerging Businesses at US Oncology, Inc. from 2010 to 2011; Executive VP-Integrated Oncology Solutions at US Oncology Holdings, Inc.; Chief Commercial Officer & Senior Vice President at Tesaro, Inc. from 2015 to 2019; and Senior VP-Pharmaceutical & Biotech Solutions at McKesson Specialty Health, Inc. Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at Dartmouth College.

Aktiva positioner av Grant Bogle

FöretagPositionStart
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -
Direktör/Styrelseledamot -

Tidigare kända positioner av Grant Bogle

FöretagPositionSlut
NUVALENT, INC. Direktör/Styrelseledamot 2026-07-15
TESARO INC Företagsledare/Principal 2019-01-22
EPIZYME, INC. Verkställande Direktör -
Företagsledare/Principal -
Företagsledare/Principal -
Se detaljerna i Grant Bogles erfarenhet

Grant Bogles utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

65

Första gradens relationer

16

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag16

Process Industries

Health Technology

Health Services

Commercial Services

Health Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Grant Bogle